Changing Patterns of Causes of Death in Patients With Multiple Myeloma During the Modern Therapeutic Era
Clinical Lymphoma Myeloma and Leukemia · 2026-11 · 26 (11) · e1338-e1345
DOI: 10.1016/j.clml.2026.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-11. Verfasst von Abel Rosado-Rodriguez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Hospital of Jerez, Jerez de la Frontera, Spain. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Therapeutic advances have substantially prolonged survival in multiple myeloma (MM). However, real-world evidence on temporal changes in causes of death remains limited. This study evaluated how mortality patterns have evolved during the era of novel therapies. PATIENTS AND METHODS: We conducted a retrospective real-world cohort study including 469 consecutive patients with MM managed at a tertiary referral center between 2000 and 2025. The primary analysis included 230 patients who died between 2008 and 2025. Causes of death were independently adjudicated by 2 hematologists using a predefined hierarchical classification based on the underlying cause of death. RESULTS: MM progression remained the leading cause of death but declined significantly across study periods, from 86.4% in 2008 to 2013 to 62.5% in 2020 to 2025 (P = .001). Conversely, non-MM-related deaths increased from 7.6% to 31.8%. Early deaths decreased significantly (28.8% vs. 9.1%; P = .004). Cardiovascular and infectious terminal events became more frequent, whereas multiorgan failure became less frequent. CONCLUSION: The distribution of causes of death among deceased patients with MM has changed over time, with a declining proportion of deaths due to disease progression and an increasing contribution of competing non-MM causes. As survival improves, these findings support integrating cardiovascular care, infection prevention, and long-term management of comorbidities into MM survivorship strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, University Hospital of Jerez, Jerez de la Frontera, Spain.
- Department of Hematology, University Hospital of Jaén, Jaén, Spain. Electronic address: eortegavida@gmail.com.
- Intensive Care Unit, Virgen de las Nieves University Hospital, Granada, Spain.
- Department of Pharmacy, University Hospital of Jerez, Jerez de la Frontera, Spain.
Zitieren
APA
Rosado-Rodriguez, A., Ortega-Vida, E., Cárdenas-Cruz, A., Fe, R., Verdugo, V., Gavira, R., Rossi-Vargas, B., López-Pulido, I., Hernández-Sánchez, P., & Garzón, S. (2026). Changing Patterns of Causes of Death in Patients With Multiple Myeloma During the Modern Therapeutic Era. Clinical Lymphoma Myeloma and Leukemia, 26(11), e1338-e1345. https://doi.org/10.1016/j.clml.2026.09.004
Vancouver
Rosado-Rodriguez A, Ortega-Vida E, Cárdenas-Cruz A, Fe R, Verdugo V, Gavira R, et al. Changing Patterns of Causes of Death in Patients With Multiple Myeloma During the Modern Therapeutic Era. Clinical Lymphoma Myeloma and Leukemia. 2026;26(11):e1338-e1345. doi:10.1016/j.clml.2026.09.004
BibTeX
@article{RosadoRodriguez2026,
author = {Rosado-Rodriguez, Abel and Ortega-Vida, Esther and Cárdenas-Cruz, Antonio and Fe, Rocío and Verdugo, Victoria and Gavira, Rocío and Rossi-Vargas, Beatriz and López-Pulido, Irene and Hernández-Sánchez, Pilar and Garzón, Sebastián},
title = {Changing Patterns of Causes of Death in Patients With Multiple Myeloma During the Modern Therapeutic Era},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {11},
pages = {e1338--e1345},
doi = {10.1016/j.clml.2026.09.004}
}
EUVIMED